Associated Papers
A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy.
Hernandez I et al.
Science Translational Medicine, 2019
Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.
Lee JH et al.
Neuron, 2015
Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.
Subramaniam S et al.
Science (new York, N.y.), 2009
Select a paper to view details